Detalles de la búsqueda
1.
Duration of androgen deprivation therapy with postoperative radiotherapy for prostate cancer: a comparison of long-course versus short-course androgen deprivation therapy in the RADICALS-HD randomised trial.
Lancet
; 2024 May 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-38763153
2.
Adding 6 months of androgen deprivation therapy to postoperative radiotherapy for prostate cancer: a comparison of short-course versus no androgen deprivation therapy in the RADICALS-HD randomised controlled trial.
Lancet
; 2024 May 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-38763154
3.
Olaparib plus abiraterone versus placebo plus abiraterone in metastatic castration-resistant prostate cancer (PROpel): final prespecified overall survival results of a randomised, double-blind, phase 3 trial.
Lancet Oncol
; 24(10): 1094-1108, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37714168
4.
Which patients with metastatic hormone-sensitive prostate cancer benefit from docetaxel: a systematic review and meta-analysis of individual participant data from randomised trials.
Lancet Oncol
; 24(7): 783-797, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37414011
5.
Abiraterone acetate plus prednisolone with or without enzalutamide for patients with metastatic prostate cancer starting androgen deprivation therapy: final results from two randomised phase 3 trials of the STAMPEDE platform protocol.
Lancet Oncol
; 24(5): 443-456, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37142371
6.
Abiraterone acetate and prednisolone with or without enzalutamide for high-risk non-metastatic prostate cancer: a meta-analysis of primary results from two randomised controlled phase 3 trials of the STAMPEDE platform protocol.
Lancet
; 399(10323): 447-460, 2022 01 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-34953525
7.
Prostate cancer outcomes following whole-gland and focal high-intensity focused ultrasound.
BJU Int
; 132(5): 568-574, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37422679
8.
Patient-reported outcomes with olaparib plus abiraterone versus placebo plus abiraterone for metastatic castration-resistant prostate cancer: a randomised, double-blind, phase 2 trial.
Lancet Oncol
; 23(10): 1297-1307, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-36063830
9.
Cardiovascular Safety of Degarelix Versus Leuprolide in Patients With Prostate Cancer: The Primary Results of the PRONOUNCE Randomized Trial.
Circulation
; 144(16): 1295-1307, 2021 10 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-34459214
10.
Abiraterone acetate plus prednisolone for metastatic patients starting hormone therapy: 5-year follow-up results from the STAMPEDE randomised trial (NCT00268476).
Int J Cancer
; 151(3): 422-434, 2022 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35411939
11.
Radiotherapy to the prostate for men with metastatic prostate cancer in the UK and Switzerland: Long-term results from the STAMPEDE randomised controlled trial.
PLoS Med
; 19(6): e1003998, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35671327
12.
Transdermal oestradiol for androgen suppression in prostate cancer: long-term cardiovascular outcomes from the randomised Prostate Adenocarcinoma Transcutaneous Hormone (PATCH) trial programme.
Lancet
; 397(10274): 581-591, 2021 02 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-33581820
13.
Impact of the COVID-19 pandemic on the diagnosis and treatment of men with prostate cancer.
BJU Int
; 130(2): 262-270, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35080142
14.
Urinary incontinence and use of incontinence surgery after radical prostatectomy: a national study using patient-reported outcomes.
BJU Int
; 130(1): 84-91, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34846770
15.
Interventions for obstructive uropathy in advanced prostate cancer: a population-based study.
BJU Int
; 130(5): 688-695, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35485254
16.
Timing of radiotherapy after radical prostatectomy (RADICALS-RT): a randomised, controlled phase 3 trial.
Lancet
; 396(10260): 1413-1421, 2020 10 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-33002429
17.
How reliable are surgeon-reported data? A comparison of the British Association of Urological Surgeons radical prostatectomy audit with the National Prostate Cancer Audit Hospital Episode Statistics-linked database.
BJU Int
; 128(4): 482-489, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-33752249
18.
Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy.
N Engl J Med
; 377(4): 338-351, 2017 07 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-28578639
19.
Risk Factors and Treatment Outcomes of 1,375 Patients with Testicular Leydig Cell Tumors: Analysis of Published Case Series Data.
J Urol
; 203(5): 949-956, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-31845841
20.
Associations of urological malignancies with renal progression and mortality in advanced chronic kidney disease: a propensity-matched cohort study.
BMC Nephrol
; 21(1): 202, 2020 05 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-32471368